NEW YORK, USA – June 8, 2026
DarioHealth Corp. has unveiled four new studies at the American Diabetes Association (ADA) Scientific Sessions, demonstrating the clinical and commercial value of its integrated digital health platform across high-risk cardiometabolic populations. The latest findings add to a growing body of evidence from 27 studies presented by Dario at ADA over the past eight years, reinforcing the company’s strategy of expanding beyond traditional digital health services into outcomes-based and claims-driven healthcare models. The research highlights significant improvements in weight management, diabetes control, healthcare utilization, and long-term patient engagement, providing further validation of Dario’s AI-powered platform as healthcare systems increasingly seek scalable solutions for chronic disease management. The studies also strengthen the company’s position among health plans, employers, and enterprise healthcare buyers looking for measurable clinical outcomes and cost savings through digital therapeutics and personalized care interventions.
Digital Platform Delivers Significant Weight Loss and Diabetes Improvements
Among the most notable findings, participants using Dario’s platform achieved an average weight loss of 6.4% at 12 months without medication support, while those combining the platform with GLP-1 therapy achieved an impressive 14.3% weight reduction, surpassing benchmarks commonly associated with medication-only approaches. The data underscore the growing role of digital interventions in enhancing the effectiveness of pharmacological therapies and supporting sustainable behavior change.
Researchers also reported strong improvements in diabetes management, with 44.8% of high-risk diabetes users achieving at least a 1% reduction in estimated HbA1c (eA1c) levels over 12 months. These outcomes are particularly significant given the established relationship between improved glycemic control and reduced risk of diabetes-related complications. The findings suggest that combining personalized digital support, connected health monitoring, and continuous coaching can help patients achieve meaningful improvements in metabolic health while promoting long-term engagement in disease management programs.
Reduced Hospitalizations Strengthen Economic Value Proposition
Advertisement
Beyond clinical outcomes, the studies demonstrated the platform’s potential to generate measurable economic benefits for healthcare organizations and payers. Compared with control populations, participants experienced 0.23 fewer hospitalizations per patient per year, highlighting Dario’s ability to reduce acute healthcare utilization among high-risk individuals living with diabetes, hypertension, and obesity. Reduced inpatient admissions represent a key metric for health plans and employers seeking to lower healthcare expenditures while improving population health outcomes.
Previous Dario analyses have associated similar utilization reductions with estimated annual payer savings of approximately $5,077 per participant, emphasizing the broader financial implications of sustained digital engagement. The latest data reinforce the growing recognition that effective chronic disease management platforms can contribute not only to better patient outcomes but also to meaningful reductions in healthcare costs through prevention, monitoring, and early intervention strategies.
Sustained Engagement Drives Long-Term Cardiometabolic Outcomes
A central theme emerging from all four studies was the importance of consistent user engagement. Researchers found that participants who remained actively engaged with the platform were significantly more likely to achieve favorable outcomes across multiple cardiometabolic measures, including weight loss, glycemic control, and healthcare utilization. Dario attributes these results to its integrated care model, which combines artificial intelligence-driven engagement tools, connected monitoring devices, personalized coaching, and behavioral support interventions.
Rather than addressing individual chronic conditions separately, the platform is designed to manage overlapping cardiometabolic disorders through a single, coordinated digital ecosystem. This integrated approach helps reduce fragmentation in care delivery while supporting sustained lifestyle modifications and healthier long-term behaviors. As healthcare systems increasingly prioritize value-based care and outcomes-driven reimbursement models, Dario’s latest ADA findings provide compelling evidence that digital health platforms can play an increasingly important role in managing chronic diseases, improving patient outcomes, and supporting more efficient healthcare delivery across diverse patient populations.
Source: DarioHealth press release
